Tuberous Sclerosis Alliance

Nov 17, 2020

Tuberous Sclerosis Alliance Announces Director, Medical Affairs

Jul 31, 2020

Tuberous Sclerosis Alliance Lauds FDA Approval of Epidiolex® to Treat Seizures in People with Tuberous Sclerosis Complex

Jun 19, 2020

Tuberous Sclerosis Alliance and Seizure Tracker(TM) Partner to Promote Data Sharing and Biosample Collection

Mar 04, 2020

Jay Mohr to Headline 19th Annual Comedy for a Cure® on April 5, 2020

Jan 27, 2020

Tuberous Sclerosis Alliance Lauds Lundbeck And FDA For Sabril Label Expansion For Patients 2 To 10 Years Old

Sep 17, 2019

Tuberous Sclerosis Alliance to Mark 45th Anniversary at Gala in New York City

Apr 30, 2019

TSC Global Awareness Day Scheduled for May 15

Nov 29, 2018

Tuberous Sclerosis Alliance Preclinical Consortium Announces New Staff and Company Members

May 15, 2018

Tuberous Sclerosis Alliance Announces New Global Partnerships in India and Thailand

Apr 30, 2018

Tuberous Sclerosis Complex Global Awareness Day Scheduled for May 15

Apr 10, 2018

Tuberous Sclerosis Alliance salutes FDA approval of Afinitor® DISPERZ (everolimus) as the first adjunctive treatment approved in US for patients aged 2 years and older with tuberous sclerosis complex (TSC)-associated partial-onset seizures

Jan 04, 2018

Tuberous Sclerosis Alliance Announces New Global Partnership in Hungary

Oct 27, 2017

Tuberous Sclerosis Alliance Submits "Voice of the Patient" Report To FDA